Acting White House director of AIDS policy Patricia Fleming has been named to the permanent post. A former assistant to the Secretary of Health and Human Services, she succeeds Katherine Gebbie, who gave overinflated expectations as the reason for her resignation after only 11 months.
Ms Fleming says her chief mission is shaping the AIDS budget from its beginnings until approval by Congress. She will also be the liaison with community groups and will try to promote cooperation among AIDS programs in different federal agencies. More money should be spent on research into vaginal microbicides and on the female condom, she says, and more effort put into halting the rise in infection, especially among women, adolescents and minorities.
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
7 day trial access
Become a subscriber
Or £77 per month
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Copyright © The Pharma Letter 2024 | Headless Content Management with Blaze